Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 11,241–11,260 of 17,974 drug recalls

Drug Recall Ongoing Historical recordClass II

TriMix, Alprostadil/Phentolamine/Papaverine 20mcg/1mg/30mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

TriMix, Alprostadil/Phentolamine/Papaverine 10mcg/1mg/30mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

TriMix, Alprostadil/Phentolamine/Papaverine 10mcg/0.5mg/30mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

TriMix, Alprostadil/Phentolamine/Papaverine 40mcg/2mg/30mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Tri-Amino (Ornithine (L) HCL 100 mg/Arginine HCL 100 mg/Citrulline (L) 100 mg/Lidocaine HCL 10 mg/mL, (30 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Testosterone Suspension 100 mg/mL, (5 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Testosterone Enanthate in Sesame Oil, 200 mg/mL, (5 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Testosterone Cypionate/Enanthate/Propionate, 160 mg/20 mg/20 mg/mL, (5 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Testosterone Cypionate/Propionate, 200 mg/50 mg/mL, (5 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Testosterone Cypionate in Sesame Oil, 250 mg/mL, (5 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Testosterone Cypionate/Zinc Gluconate in Sesame Oil, 200 mg/2 mg/mL, (5 ML and 10 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Testosterone Cypionate in Sesame Oil, 200 mg/mL, (5 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Testosterone Cypionate in Grapeseed, 200 mg/mL, (5 ML and 10 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Testosterone Cypionate in Sesame, 150 mg/mL, (5 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Testosterone Cypionate in Sesame, 100 mg/mL, (5 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Taurine 50 mg/mL, (30 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Slim Shot (Methionine (L) 25mg/Inositol 50mg/Choline Chloride 50mg/Methylcobalamin 1 mg/Pyridoxine HCL 2.2mg/ml), (30 ML). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Sermorelin GT (Sermorelin Acetate 15 mg/GHRP-2 5.4 mg/Theanine (L) 75 mg). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Sermorelin Forte Plus 27 mg (Sermorelin Acetate 9 mg/GHRP-6 9 mg/GHRP-2 9 mg). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Sermorelin Forte Plus 18 mg (Sermorelin Acetate 6 mg/GHRP-6 6 mg/GHRP-2 6 mg). Compounded by Tri-Coast Pharmacy

by Tri-Coast Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
November 17, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.